CING (cingulate.com) Net Profit

CING (Cingulate) - company brandmark

Cingulate Inc. is developing the CTR precision ecosystem for the therapy of CNS disorders, as evidenced by the company's net profit margin provided by the GURU.Markets system, where -0.03 serves as the base parameter value. Growth depends on the regulation of psychotropics and safety tests. The current strategy relies on local partnerships for conducting clinical trials without pursuing mergers.

CING (Cingulate) Company Net Income history from 07/04/2022 to 10/29/2026

Comprehensive metric breakdowns and analytics for cingulate.com (CING)

- price and consensus price forecast:
Stock Quotes Cingulate|CING - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Cingulate Inc.|CING - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Cingulate|CING - Company Book Value|Market Capitalization to Net Assets cingulate.com|CING - Aggregate Company Assets
- debt and solvency information:
Total Debt to Capital Coefficient Cingulate Inc.|CING - Long-Term Debt to Equity Ratio|Current Liabilities to Capital Cingulate|CING - Company Aggregate Debts|Debt to Book Value Cingulate Inc.|CING - Company Long-Term Debts|Company Short-Term Loans and Borrowings Cingulate|Immediate Liquidity cingulate.com
- net income and valuation multiples indicators:
CING - Net Profit
Fundamental valuation:CING, Cingulate Corp
Mass-produced product of Cingulate Inc.

This indicator measures the final cash balance after deducting all operating and tax liabilities, allowing the investor to assess the business's actual ability to generate value. The net financial profit trend of Cingulate Inc. (CING) reflects capital stability, which is critical for Cingulate Inc. (CING) when implementing innovative extended-release drug delivery systems for ADHD to stabilize patient conditions.

Direct competitors

Net Income Alkermes Corp|AVDL (Avadel Pharmaceuticals) - Net Profit|Net Profit atai.life|Net Income GHRS (GH Research)|MNMD (Mind Medicine (MindMed) Inc.) - Final Profit|Company Net Income Compass Pathways CMPS|LBRX (LB Corp) - Profit After Tax|DRUG - Company Net Income|Net Financial Result vandapharma.com VNDA|CYBN (cybin.com) - Net Income|Company Net Income Alto Neuroscience Inc (ANRO)|NRXP (NRx Pharma) - Net Profit|Net Income silopharma.com (SILO)|Net Profit CPHI|CMND (Clearmind Medicine, Inc.) - Final Profit|Company Net Income Psyence Biomedical PBM|SciSparc Ltd. (SPRC) - Company Net Income|Seelos Therapeutics, Inc - Net Profit|Virpax Pharmaceuticals (VRPX) - Net Income|KRTX: Net Profit